Post-marketing safety surveillance and re-evaluation of Xueshuantong injection.
BMC Complement Altern Med
; 18(1): 277, 2018 Oct 16.
Article
in En
| MEDLINE
| ID: mdl-30326892
Key words
Full text:
1
Database:
MEDLINE
Traditional Medicines:
Medicinas_tradicionales_de_asia
/
Medicina_china
Main subject:
Product Surveillance, Postmarketing
/
Drugs, Chinese Herbal
/
Drug-Related Side Effects and Adverse Reactions
Type of study:
Etiology_studies
/
Guideline
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Country/Region as subject:
Asia
Language:
En
Journal:
BMC Complement Altern Med
Year:
2018
Type:
Article